{predictNMB}{predictNMB}
Currently:
PhD Candidate and Senior Research Assistant at AusHSI (QUT)
Previously:
Work
2019-2020
2018-2019
2016-2018
School
2019-2020
2015-2017
2012-2014
Generic measure of disease burden that considers quality and duration of life
“The maximum price at or below a customer would pay for a product”
AKA
“The price at which a healthcare payer is willing to pay for an additional quality-adjusted life year”
\[ICER = \frac{Cost_{treatment}-Cost_{ref}}{QALY_{treatment}-QALY_{ref}}\]
ICER = Cost per additional QALY gained
NMB: Summary of benefit in monetary terms
\[NMB = QALY \times WTP - Cost_{treatment}\] INB: Difference in NMB between two strategies
\[INB_{treatment} = NMB_{treatment} - NMB_{ref}\]
{predictNMB}{predictNMB} What is the expected health economic benefit of using a given (hypothetical) CDSS?